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Intrauterine  growth  restriction  (IUGR)  is a pleiotropic  complication  of pregnancy.  Prematurity  and  growth
abnormalities  are  common  risk  factors  for  perinatal  morbidity  and  mortality.  Free  radical  damage  has
been recognized  as a common  pathogenic  mechanism  of  many  neonatal  diseases.  The aim  of the present
study  was  to  characterize  the  possible  links between  the level  of maturity,  the  birthweight  and  the






the  cord  blood  of  neonates  with  IUGR  and  mature,  healthy  neonates  do not  necessarily  reﬂect  the  extent
of oxidative  stress.  However,  signiﬁcant  correlations  were  found  between  the maturity  of the  neonates
with  IUGR  and  the oxidative  damage.  The  mature  IUGRs  exhibited  ONOO− accumulation  and  increased
lipid  peroxidation  more  frequently  as  compared  with the  pre-term  group.  The  results  suggest  that  the
oxidative  injury  in  IUGR  may  depend  on  the  level  of maturity  and  the birthweight.
© 2015  Elsevier  Inc.  All  rights  reserved.. Introduction
Pregnancy is a physiological state associated with an enhanced
etabolism and an increased demand for oxygen. Premature
nfants are at particular risk from oxidative stress, as neither
he endogenous nor the passively acquired exogenous antioxi-
ant defence system accelerates in maturation until late in the
hird trimester [1,2]. Intrauterine growth restriction (IUGR) is
ne of the major complications of pregnancy and accounts for
igniﬁcant neonatal mortality and morbidity [3]. The develop-
ent of IUGR may  be a consequence of various factors, including
n abnormal fetomaternal blood circulation, genetic disorders,
regnancy-induced hypertension, pregestational diabetes, a lean
mbilical cord, previous intrauterine infections, a poor nutritional
tate of the mother, frequent cigarette smoking [4] and toxin or
rug exposure [5]. However, in the vast majority of the cases the
ause remains idiopathic.
IUGR is often complicated by intrauterine hypoxia and may
nduce the generation of reactive oxygen species (ROS) and foetal
xidative stress, resulting in serious consequences for the foetus,
uch as low birthweight and prematurity [6]. Neonates with IUGR
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890-6238/© 2015 Elsevier Inc. All rights reserved.are more susceptible to ROS-induced oxidative damage because
their enzymatic and non-enzymatic antioxidant defence systems
and the ability to undergo induction during a hyperoxic challenge
are impaired [7].
To eliminate the harmful effects of ROS, cells are equipped
with an efﬁcient antioxidant defence system, including enzymes
such as superoxide dismutase (SOD), catalase (CAT), hemeoxy-
genases (HOs), and low-molecular weight antioxidants such as
glutathione (GSH) and metallothioneins (MTs) [8,9]. SOD catal-
yses the reduction of the superoxide anion (O2 ˙−) to hydrogen
peroxide (H2O2). In a subsequent step, CAT stimulates the degra-
dation of H2O2 to molecular oxygen and water [10]. The MTs  are
small proteins with unusually high cysteine content. This confers
their high metal-binding and ROS-reducing properties [11]. The
HOs play roles in heme degradation, yielding equimolar quantities
of biliverdin, carbon monoxide (CO) with important free radical-
scavenging properties and free Fe ions. In mature neonates, a
considerable proportion of the plasma total antioxidant capacity
originates from bilirubin [12]. HO-2 is a constitutive, and HO-1 an
inducible isoform of HO, an antioxidative, anti-inﬂammatory and
cytoprotective enzyme that is induced in response to cellular stress,
including oxidative stress [13].
Nitric oxide (NO) may  be an important factor for the regulation
of blood pressure and oxygen delivery to the foetus [14]. Umbili-
cal cord blood vessels lack innervations, and endothelial cells must
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Table  1
Clinical parameters of the study groups and the maternal age. Data are expressed as means ± SD. The minimum and the maximum values of the parameters are given in
parentheses.
Full-term neonates with normal weight Full-term neonates with IUGR Pre-mature neonates with IUGR
Gestational age at delivery (weeks) 39.2 ± 0.77 (38–40 + 2) 38.74 1.31 (37–40+4) 34.01 ± 1.62 (30–36)














































tThe  pH of blood samples 7.25 ± 0.11 (7.04–7.42) 
1  min  APGAR 8.83 ± 1.37 (6–10) 
Maternal age (years) 29.9 ± 5.74 (22–42) 
herefore play a major role in the local control of blood ﬂow [15].
O derived from endothelial nitric oxide synthase (eNOS) is consid-
red the main vasodilator agent in fetoplacental vessels [16]. The
imultaneous generation of NO and O2 ˙− in sufﬁciently high con-
entrations in the same compartment favours the production of a
oxic reaction product, peroxynitrite anion (ONOO−). ONOO− and
ther reactive nitrogen species can affect the cell functions through
he oxidation or nitration of various cellular targets [17].
Under stress conditions, genes coding for molecules involved
n biological defence and cellular repair are markedly upregulated,
nd the changes in gene expression can be characteristic, sensi-
ive and measurable endpoints [18]. Members of this antioxidant
efence system are useful biomarkers of the oxidant–antioxidant
tatus of neonates with IUGR. The aim of the present study was
o characterize the possible links between the level of maturity,
he birthweight and the antioxidant status of neonates born with
UGR. We  report data on macromolecular damage, the accumula-
ion of powerful oxidants such ONOO−, H2O2, the activities of the
ntioxidant enzymes SOD and CAT, and the expressions of a set
f genes coding for members of antioxidant defence system (sod1,
od2, cat,  mt-1, mt-2, ho-1, ho-2 and enos) from the aspects of the
evel of maturity and the birthweight of neonates with IUGR.
. Materials and methods
.1. Human subjects
The blood samples were obtained from the Department of
bstetrics and Gynaecology at the University of Szeged, Hungary.
he Ethics Committee of the Department of Obstetrics and
ynaecology approved the study protocol (149/2012). 24 mature
eonates with normal weight and 28 mature and 28 premature
eonates with IUGR of either sex were examined. The neonates
ere considered premature if they were born before the gesta-
ional age of 37 weeks and full-term if the delivery occurred after 37
eeks. Newborns that had a history of difﬁcult delivery and foetal
istress, or showed malformations or evidence of genetic disorders
ere excluded. The nutritional status of the mothers during preg-
ancy was satisfactory; no case of malnutrition occurred. Smoking
others and their neonates were also excluded from this study.
Blood was taken from the umbilical artery, before the birth of
he placenta. Blood coagulation was inhibited by EDTA. The blood
amples were centrifuged at 3000 rpm for 20 min  at 4 ◦C, and the
lasma and the buffy coat were removed. The red blood cell (RBC)
hase was washed twice with 2 volumes of isotonic saline solu-
ion at pH 7.0. The samples were stored at −80 ◦C until processing
Table 1).
.2. RNA extraction, reverse transcription and PCR ampliﬁcation
Approximately, 100 mg  of frozen RBC were homogenized in RNA
ee reagent (Tel-Test, Inc.) and total RNAs were prepared accord-
ng to the procedure suggested by the manufacturer. Total RNA was
outinely treated with 100 U RNAse-free DNAseI (Thermo Scien-
iﬁc) to avoid any DNA contamination.7.24 0.088 (7.1–7.36) 7.20 ± 0.142 (7.05–7.3)
8.36 1.65 (6–10) 7 ± 1.63 (4–9)
28.9 6.55 (20–41) 29.3 ± 7.22 (21–42)
For the quantiﬁcation of mt-1 and mt-2, sod1 and sod2, cat,
enos, ho-1 and ho-2 mRNAs, reverse transcription followed PCR
ampliﬁcations (RT-PCRs) were performed. First-strand cDNAs were
synthesized by using 5 g total RNAs as templates, 200 pmol of
each dNTP (Thermo Scientiﬁc), 200 U Maxima H Minus Reverse
Transcriptase (Thermo Scientiﬁc) and 500 pmol random hexamer
primers (Sigma) in a ﬁnal volume of 20 L, and incubated for 10 min
at 37 ◦C, followed by 1 h at 52 ◦C. One microliter reverse transcrip-
tion product was  added to 25 L DreamTaq Green PCR Master Mix
2x (Thermo Scientiﬁc). Ampliﬁcation was performed in a PTC 200
Peltier Thermal Cycler (MJ  Research) using 15 cycles of 95 ◦C for
30 s, 55 ◦C for 30 s, and 72 ◦C for 30 s for the 18S rRNA, used as inter-
nal reference and 30 cycles for mt-1 and mt-2, sod1 and sod2, cat,
enos, ho-1 and ho-2 mRNAs, respectively. The ampliﬁed products
were detected on a 2% agarose gel. The relative levels of mRNAs are
expressed as ratios (mRNA/18S rRNA).
2.3. Primers
The following primer sets were selected: sod1: F: aagatg-
gtgtggccgatgtg and R: ctacagctagcaggataacag; sod2: F: caag-
gctcaggttggggttg and R: gctgggatcattagggtagtatg; cat: F: cacagaa-
gatggtaactggg and R: ggcgatgtccatctggaatc; enos: F: cactgagcccgtg-
gcagtag and R: ggcaggcagcgccaccgacg; mt-1: F: atggaccccaactgctc-
ctg and R: gttcccacatcaggcacagc; mt-2: F: atggaccccaactgctcctg
and R: cggtcacggtcagggttgtac; ho-1: F: gctgctggtggcccacgctt and
R: ctctggtccttggtgtcatgg; ho-2: F: tggcccacgcatacacccgc and R:
ggtctctctggccagtgtgga. For the normalization of sods, cat,  enos, mts
and hos mRNAs, the level of carp 18S rRNA was  used as internal
standard, detected with primer pairs F: gaaacggctaccacatccaagg,
and R: ccgctcccaagatccaactacg.
2.4. Densitometry
Images of the ethidium bromide-stained agarose gels were dig-
itized with a GDS 7500 Gel Documentation System and analyzed
with the GelBase/GelBlotTM Pro Gel Analysis Software (UVP).
2.5. Enzyme activity measurement
The RBCs were hemolysed by the addition of distilled water at a
ratio of 1:9. Except for SOD activity determinations, the aliquots of
the hemolysates were used directly. The quantity of protein was
determined with Folin reagent, using bovine serum albumin as
standard [19]. Biomate 5 Double-Beam UV–vis photometer recor-
ding (Thermo Spectronic) was used for SOD measurements and
GENESYS 10S UV–vis spectrophotometer (Thermo Scientiﬁc) was
used for all the other parameters.
SOD (EC 1.15.1.1) activity was  determined on the basis of the
inhibition of the epinephrine–adrenochrome autoxidation [20].
Spectrophotometric measurement was carried out at 480 nm. The
results were expressed in U/mg protein.
CAT (EC 1.11.1.6) activity was determined spectrophotometri-
cally at 240 nm by the method of Beers and Sizer [21] and speciﬁc
























Fig. 3. Fold of change in the levels of ONOO-, H2O2, lipid peroxidation (TBARS), and
the CAT activity in the cord red blood cells of mature and premature neonates with
IUGR. For normalization the levels of mature, healthy neonates were used as refer-
F
rig. 1. The levels of ONOO− , H2O2, lipid peroxidation (TBARS), and the CAT activity
n  the cord red blood cells of mature, healthy neonates (C) and neonates with IUGR.
ata were expressed as means ± SEM from measurements on 24/56 samples.
AT activity was  expressed in Bergmeyer units (BU)/mg protein (1
U = decomposition of 1 g H2O2/min at 25 ◦C).
.6. Lipid peroxidation estimation assay
The level of thiobarbituric acid-reactive substances (TBARS) is
egarded as an appropriate indicator of the extent of lipid peroxi-
ation (LPO) [22]. LPO was estimated by a TBARS assay at 532 nm
gainst a blank that contained the thiobarbituric acid (TBA) reagent
0.15 g/mL TCA, 3.75 × 10−3 g/mL TBA and 0.25 M HCl) as described
y Serbinova et al. [23].
.7. Determination of H2O2 production
For the assay of H2O2, 0.05 mg/mL  horseradish peroxidase and
.1 mg/mL  o-dianisidine in sodium phosphate buffer (100 mM,  pH
.5) was used. The H2O2 concentration was determined spec-
rophotometrically at 400 nm and was calculated as nmol/mg
rotein [24].
.8. Determination of ONOO− production
ONOO− was assayed by diluting samples into 1.0 M NaOH (60:1)
nd measuring the increase in absorbance at 302 nm.  As a con-
rol, samples were added to 100 mM potassium phosphate (pH 7.4)
60:1). The decrease in absorbance was measured at neutral pH as
NOO− decomposes [25].9. Statistical analysis
Statistical differences were calculated with one-way analysis






























ig. 2. mRNA expression level of antioxidant genes in the cord red blood cells of mature
RNA  was  used as an internal standard. Data were expressed as means ± SEM from measuence. Signiﬁcant difference was accepted at a/bp ≤ 0.05. (a) A signiﬁcant difference
between the mature, healthy neonates and neonates with IUGR. (b) A signiﬁcant
difference between the mature and premature neonates with IUGR.
Broekstraat, Belgium) with a Student–Newman–Keuls follow-up
test. Signiﬁcant difference was accepted at a,bp ≤ 0.05, aap ≤ 0.01
and aaap ≤ 0.001.
3. Results
3.1. Comparative studies of mature, healthy neonates and
neonates with IUGR
The levels of oxidant molecules (H2O2 and ONOO−) and thio-
barbituric acid-reactive substances (TBARS) and the activity of the
H2O2-degrading CAT did not differ signiﬁcantly between the IUGR
and control groups (Fig. 1).
As concerns the mRNA levels of genes coding for antioxidant
molecules, signiﬁcantly lower amounts were measured for cat
(∼20%), ho-1 (∼40%) and ho-2 (∼50%) in the IUGR group than in the
controls. The mt-2 mRNA level was approximately 1.5-fold higher
in the neonates with IUGR than in the control group (Fig. 2). As
a consequence of the relatively high individual ﬂuctuations, the
averages of the amounts of mt-1, sods and enos mRNA did not differ
signiﬁcantly (Fig. 2).
3.2. Comparative studies of mature and premature neonates with
IUGR
There was  no signiﬁcant difference in the level of H2O2 or the
activity of CAT between the mature and pre-term neonates with
IUGR. However, the mature group exhibited a 1.5-fold higher accu-
mulation of ONOO−, and also a higher TBARS level (Fig. 3). The levels
of ONOO− and TBARS for the pre-term IUGR neonates were was
more similar to those for the normal controls.
       sod-2          sod-1            cat enos
aa
, healthy neonates (C) and neonates with IUGR. For normalization the level of 18S
rements on 24/28 samples. ap < 0.05, aap < 0.01.1.
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aere  used as references. Signiﬁcant difference was  accepted at a,bp ≤ 0.05, aap ≤ 0
eonates with IUGR. (b) A signiﬁcant difference between the mature and prematur
Marked differences were also observed between the mRNA lev-
ls of selected parameters in the groups of mature and premature
UGR neonates. There was a ∼60% difference in the level of the mt-1
nd mt-2 mRNAs. The mRNA levels of both genes were approxi-
ately doubled in the mature IUGR neonates as compared with
he pre-term IUGRs and also the normal controls (Fig. 4A). The tran-
cription products of the ho genes were considerably lower in both
UGR groups; in the mature IUGRs, the levels of ho-1 and ho-2 mRNA
ere ∼50% and 40% of those for the control. In the premature IUGR
roup, both mRNA levels were lower by 25%, though these changes
ere not signiﬁcant. The level of cat mRNA was likewise lower in
oth IUGR groups: a signiﬁcant ∼25% decreases were detected. The
ranscripts of the sod genes in the mature IUGR group were ∼1.5-
old those measured in the control and premature IUGR groups. In
he premature IUGR group, the enos mRNA was ∼3-fold that in the
ature IUGR group (Fig. 4B). In this case, the mature neonates with
r without IUGR exhibited similar mRNA levels.
. Discussion
Since IUGR is postulated to be a pleiotropic complication of
regnancy, the identiﬁcation of unit marker molecules or reaction
athways connected with this disorder poses a number of difﬁcul-
ies. Various studies have focused on the antioxidant status of IUGR
r premature neonates, but only brief accounts have been given as
oncerns the comparison of premature and full-term neonates with
UGR from any aspect. The major ﬁnding of the present study is the
mportance of the age-based grouping of neonates with IUGR. Sig-
iﬁcant differences in the levels of speciﬁc stress markers relative
o the control group were observed only when the full-term and
re-term IUGR neonates were grouped separately.
A higher degree of oxidative stress was detected in the cord
lood of mature IUGR neonates as compared with the control and
re-term IUGR groups; the level of ONOO− was almost twice as
igh, indicating increased O2 ˙− and NO production. The simulta-
eous generation of NO and O2 ˙− in relatively high concentrations
n the same compartment favours production of the toxic reaction
roduct ONOO− [17]. Although ONOO− itself is not a free radical, it
s a powerful oxidant, whose toxicity is manifested among others
n LPO [17] and which plays a role in the pathophysiology of IUGR
26].
The elevated ONOO− and O2 ˙− levels in the cord blood of mature
eonates with IUGR were clearly reﬂected by an increased level of
BARS. NO, however, is a Janus-faced molecule. Since the umbili-
al cord blood vessels lack innervations, the NO production in the
ndothelial cells plays a major role in the local control of blood ﬂow
nd in oxygen delivery to the foetus [15]. In this study, we havep ≤ 0.001. (a) A signiﬁcant difference between the mature, healthy neonates and
ates with IUGR.
demonstrated a signiﬁcantly higher level of the mRNA of eNOS in
the cord blood samples of underdeveloped neonates with IUGR. In
these cases, the increase in eNOS expression was not paralleled by
ONOO− accumulation, suggesting an unaltered level of O2 ˙−. This is
in accord with the fact that there were no signiﬁcant differences in
the expressions of the sod genes, and the activity of SOD was  also
unaltered (data not shown). Additionally, no signiﬁcant changes
were observed in the TBARS level in the cord blood of the premature
neonates with IUGR. An insufﬁcient level of vasodilatation of the
umbilical vessels and reduced eNOS activity were earlier reported
to be associated with neonates who  were small for gestational age
[16].
Evidence has recently been accumulating that CO, best known
for its toxicity, can function in a similar manner to NO [27] or may
even interact with the NO-producing pathway [28]. CO is formed
primarily as a product of heme degradation, which is catalysed by
the HOs. The observation of substantial HO activity in the cord
tissues supports the possibility of the accumulation of CO in suf-
ﬁciently high amounts to play a role in fetoplacental blood ﬂow
regulation [29]. Our study presents evidence that the expressions
of the ho genes are markedly low in IUGR neonates (regardless of
the level of maturity) versus controls. Though the low expressions
of both ho genes were characteristic for both IUGR groups, a sig-
niﬁcant difference was observed only for the full-term neonates
with IUGR. Deﬁciencies in HO-1 have previously been found to
be associated with pregnancy disorders, such as recurrent miscar-
riages, IUGR and pre-eclampsia [30]. Our results support this: the
lower expression of ho in IUGR neonates might result in a decreased
CO level and unsatisfactory fetoplacental blood ﬂow. Moreover our
data relating to the selected antioxidant molecules suggest that ho
could serve as an indicative marker providing a possible link to the
IUGR phenotype.
The presence of IUGR in full-term neonates was accompanied by
signiﬁcantly higher levels of expression of both mt genes. MT,  an
important protein which binds bivalent metals, plays a signiﬁcant
role in numerous cellular metabolic processes, such as in main-
taining Zn and Cu homeostasis and in Cd and Hg detoxiﬁcation.
Additionally, an increased MT  level was demonstrated by Zapata
et al. in the erythrocytes of pregnant women  [31]. Elevated MT
levels have been attributed to the proliferation and differentiation
of blood cells in the process of erythropoiesis, the protective role
of erythrocytes against the action of free radicals, and increased
levels of estrogen and progesterone, hormones which induce the
synthesis of MT  [32]. A statistically signiﬁcant increase in the level
of MT  protein has additionally been revealed in the plasma and
RBCs of pregnant women and of their neonates with IUGR [4].
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emporary Zn storage and regulation of the Zn ﬂow to the foetus,
hile restricting toxic metal transfer [33] and protection against
he embryotoxic and teratogenic effects of a Zn deﬁciency [34],
hich may  be caused by cigarette smoke, alcohol, gestational infec-
ion and exposure to environmental contaminants, including heavy
etals and endocrine disrupters [35].
From an analysis of the parameters relating to the different
UGR groups, we can conclude that full-term neonates with IUGR
re at especially high risk. Pre-term neonates, at gestational ages
f 33–36 weeks demonstrate less damage in the integrity of the
ipid molecules, a signiﬁcant accumulation of the harmful oxidant
NOO− cannot be detected, and the expressions of genes coding for
ntioxidant markers are less affected. The signiﬁcantly lower LPO in
he premature neonates may  be correlated with the decreased sen-
itivity of the RBCs to oxygen radicals, or with the fact that the RBCs
f premature newborns contain a smaller quantity of unsaturated
atty acids [36]. This phenotype is not without precedent. The GSH
nd NADPH levels proved to be lower in those with gestational ages
f less than 33 weeks than in pre-term infants with gestational ages
f 33–36 weeks, and the levels of these markers were as low in full-
erm, small-for-age infants as in pre-term infants with gestational
ges of less than 33 weeks [7].
. Conclusions
Our data furnish evidence that there is extreme heterogeneity in
OS production and in the activation of the antioxidant defence sys-
em within neonates with IUGR, which is blunted by the use of mean
easurements. Intergrouping based on gestational age and birth-
eight, yielded evidence that the molecular results in the pre-term
UGR group were often similar to those for the mature, appropriate-
or-age neonates. However, the background of the IUGR phenotype
s pleiotropic, and measurements of various antioxidants provide
nly a partially adequate picture of the overall condition of the
eonates. Data emerging from different approaches to the topic
resent evidence only of the involvement of additional marker
olecules in the development of IUGR disorders. Our study indi-
ates that the levels of expression of the mt  and ho genes are good
andidates through which to characterize the IUGR phenotype.
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